Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Musk officially steps down from DOGE after wrapping...
HHS slams ‘under-tested’ mRNA technology as Trump cuts...
State Department says it will ‘aggressively’ revoke visas...
SEN. JEANNE SHAHEEN: If Trump wants a Ukraine...
Trump’s drastic NSC cuts spark debate: Does fighting...
GOP rails against ‘blatantly false’ Dem claims about...
SCOOP: GOP push for new House committee to...
Elon Musk criticism of Trump tax bill frustrates...
What’s next for DOGE after Elon Musk’s departure?...
Hamas faces ‘legitimacy crisis’ as desperate Gazans flock...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Accusations of Biden admin ‘interference’ in transgender surgery guidelines for minors probed by House GOP

by admin August 28, 2024
August 28, 2024
Accusations of Biden admin ‘interference’ in transgender surgery guidelines for minors probed by House GOP

A House Oversight Committee panel is probing accusations that the Biden administration pressured a global medical recommendations body to drop age limit guidelines for transgender care.

‘The Committee on Oversight and Accountability is investigating allegations of political interference by the U. S. Department of Health and Human Services (HHS) in third-party medical organization recommendations,’ a letter to HHS Secretary Xavier Becerra sent on Tuesday read.

‘We are concerned that HHS officials, acting in their official capacity, inappropriately applied pressure for changes to international pediatric medical standards.’

The letter was written by Rep. Lisa McClain, R-Mich., chair of the subcommittee on Health Care and Financial Services. She cited a June 2024 New York Times report that the administration pressed the World Professional Association for Transgender Health (WPATH) to remove its age limit recommendations for transgender youth surgeries because it ‘could fuel growing political opposition to such treatments.’

The pressure campaign was led by the staff of HHS Assistant Secretary for Health Adm. Rachel Levine, a transgender woman, according to the report.

‘Officials applied this inappropriate pressure by urging for the removal of age limits that expands the pool of children and adolescents recommended for irreversible gender transition surgical procedures. The Committee requests documents and information from HHS to assist our investigation of this matter,’ McClain wrote.

‘The Biden Administration’s advocacy for expanding the pool of vulnerable children subjected to life-altering procedures they may later regret is reprehensible. Emails indicating that this advocacy was done for political advantage – possibly to satisfy extremist elements of its base – is even more outrageous.’

The topic of transgender medical care, particularly for minors, has been a political lightening rod in recent years.

Backlash over the Times report prompted the White House to say it did not support gender-affirming surgery for minors. 

However, the White House later altered its response after backlash from progressive groups, telling 19th News that such surgeries ‘should be limited to adults,’ but, ‘We continue to support gender-affirming care for minors, which represents a continuum of care, and respect the role of parents, families, and doctors in these decisions.’

The 2021 medical guidelines at the heart of McClain’s Tuesday letter initially recommended lowering the acceptable age for transgender hormone therapy to 14, the age for mastectomies to 15 and 17 years for genital or hysterectomy procedures.

However, those limits were dropped from the final version of those recommendations, according to the Times.

In the outlet’s story, WPATH President Dr. Marci Bowers rejected accusations that the change was politically motivated. Bowers said ‘the politics were already evident’ and said the body ‘doesn’t look at politics when making a decision.’

Nevertheless, the subcommittee demanded that HHS turn over all relevant documents and communications by Sept. 10, and warned the department not to obstruct the probe.

‘Under your purview, HHS has not cooperated in good faith with the Committee’s oversight of HHS and its subagencies, including the Food and Drug Administration and the Centers for Medicare & Medicaid Services,’ the letter to Becerra said. 

‘It is unacceptable for HHS to interfere with congressional investigations by refusing and delaying cooperation with the Committee’s oversight.’

Fox News Digital reached out to HHS and the White House for comment but did not receive a response by press time. 

This post appeared first on FOX NEWS

previous post
Over 200 former Bush, McCain, Romney staffers endorse Harris: ‘The alternative … is simply untenable’
next post
Buffett’s Berkshire Hathaway hits $1 trillion market value, first U.S. company outside of tech to do so

You may also like

Kamala Harris’ husband Doug Emhoff responds to Trump’s...

July 24, 2024

Here’s what happened during Trump’s 11th week in...

April 5, 2025

Federal judge delays unions’ request to block DOGE...

February 15, 2025

DOJ charges Hamas leaders over ‘terrorist atrocities’ in...

September 4, 2024

Biden-appointed federal judge keeps blocking Trump admin from...

April 30, 2025

Rosie O’Donnell can’t stop talking about MAGA despite...

March 28, 2025

Dems threatening government shutdown over Elon Musk hate,...

March 11, 2025

Morning Glory: Trump’s approval ratings have never been...

December 17, 2024

Morning Glory: Top 10 lessons from the landslide

November 12, 2024

DAVE RAMSEY: Don’t wait on the Trump White...

January 22, 2025

Recent Posts

  • Musk officially steps down from DOGE after wrapping work streamlining government
  • HHS slams ‘under-tested’ mRNA technology as Trump cuts Moderna’s vaccine funding
  • State Department says it will ‘aggressively’ revoke visas for Chinese students
  • SEN. JEANNE SHAHEEN: If Trump wants a Ukraine deal, he should reread his own book
  • Trump’s drastic NSC cuts spark debate: Does fighting the ‘Deep State’ put national security at risk?

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (747)
    • Investing (2,201)
    • Politics (2,719)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.